SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LogicBio Therapeutics, Inc. - LOGC
NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of LogicBio Therapeutics, Inc. (“LogicBio” or the “Company”) (NASDAQ: LOGC). Such investors are advised to contact Robert S. Willoughby at rswilloughby …